Shares of drug companies that produce HIV treatments move up on news that three clinical trials...

|By:, SA News Editor

Shares of drug companies that produce HIV treatments move up on news that three clinical trials suggest healthy people should take HIV drugs to prevent infection with the virus that causes AIDS. The big winner would be Gilead Sciences (GILD +2.2%), which makes the first HIV treatment the FDA is reviewing for possible marketing as a preventative measure.